[ad_1]
“We should not think that this variety will dominate if we liquidate contacts locally: these are only isolated cases and in many countries they are only isolated cases,” said Professor Kęstutis Petrikonis of the Lithuanian University of Health Sciences (LSMU) at a conference. press. on Tuesday.
According to LSMU professor Mindaugas Stankūnas, the information on the resistance and infectivity of this strain to the strain is concerning.
However, according to K. Petrikonis, although the effectiveness of vaccines against this strain varies, and depends on the individual response of each human body, vaccines are effective and one of the most important tools currently available against this and other strains of the virus. . .
“We need to move faster with the current tools we have because they are effective, perhaps just a little less efficient. In any case, vaccines also protect against these varieties and, most importantly, those that now dominate,” he emphasized.
“We need to get vaccinated at this time and we must be careful, the principles are key,” said a member of the Council of Health Experts.
A variant of the new coronavirus identified in South Africa may be less sensitive to COVID-19 vaccines, according to some researchers.
To date, Lithuania has encountered a rapid spread of the British strain of coronavirus, which is more contagious and more likely to die from it.
The National Public Health Laboratory reported that the South African strain was detected in samples received from Vilnius and Kaunas counties last week.
The two cases are not related, they were confirmed in the laboratory of the Santara clinics in the capital through sequencing studies.
The sample was taken in Vilnius county on March 2, in Kaunas on March 8.
If you have any questions about the COVID-19 vaccine, please send them to our editorial staff by email. email address [email protected]
[ad_2]